Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

F Veglia, E Sanseviero, DI Gabrilovich - Nature Reviews Immunology, 2021 - nature.com
Myeloid-derived suppressor cells (MDSCs) are pathologically activated neutrophils and
monocytes with potent immunosuppressive activity. They are implicated in the regulation of …

Cyclooxygenase‐2 in cancer: a review

N Hashemi Goradel, M Najafi, E Salehi… - Journal of cellular …, 2019 - Wiley Online Library
Abstract Cyclooxygenase‐2 (COX‐2) is frequently expressed in many types of cancers
exerting a pleiotropic and multifaceted role in genesis or promotion of carcinogenesis and …

The role of Epstein–Barr virus in nasopharyngeal carcinoma

ZY Su, PY Siak, CO Leong, SC Cheah - Frontiers in microbiology, 2023 - frontiersin.org
Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …

The global landscape of EBV-associated tumors

C Shannon-Lowe, A Rickinson - Frontiers in oncology, 2019 - frontiersin.org
Epstein-Barr virus (EBV), a gamma-1 herpesvirus, is carried as a life-long asymptomatic
infection by the great majority of individuals in all human populations. Yet this seemingly …

Viral hijacking of cellular metabolism

SK Thaker, J Ch'ng, HR Christofk - BMC biology, 2019 - Springer
This review discusses the current state of the viral metabolism field and gaps in knowledge
that will be important for future studies to investigate. We discuss metabolic rewiring caused …

EBV-associated diseases: Current therapeutics and emerging technologies

S Chakravorty, B Afzali, M Kazemian - Frontiers in immunology, 2022 - frontiersin.org
EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

Current status and advances of immunotherapy in nasopharyngeal carcinoma

JY Xu, XL Wei, YQ Wang… - Therapeutic Advances in …, 2022 - journals.sagepub.com
The general immune landscape of nasopharyngeal carcinoma (NPC) renders
immunotherapy suitable for patients with NPC. Immune checkpoint inhibitors (ICIs) based on …

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma

M Liu, J Zhou, X Liu, Y Feng, W Yang, F Wu… - Gut, 2020 - gut.bmj.com
Objective Hepatocellular carcinoma (HCC), mostly developed in fibrotic/cirrhotic liver,
exhibits relatively low responsiveness to immune checkpoint blockade (ICB) therapy. As …

Epstein-Barr virus: the mastermind of immune chaos

JM Silva, CEC Alves, GS Pontes - Frontiers in Immunology, 2024 - frontiersin.org
The Epstein-Barr virus (EBV) is a ubiquitous human pathogen linked to various diseases,
including infectious mononucleosis and multiple types of cancer. To control and eliminate …

Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways

YN Liu, JF Yang, DJ Huang, HH Ni, CX Zhang… - Frontiers in …, 2020 - frontiersin.org
T cell exhaustion is an obstacle to immunotherapy for solid tumors. An understanding of the
mechanism by which T cells develop this phenotype in solid tumors is needed. Here …